Failure in the treatment of long-standing osteoporosis in cerebrotendinous xanthomatosis

Journal of the Formosan Medical Association

Volumn 96, Issue 3, 1997, Pages 225-227

  Chang, Wen Neng ^a   Lui, Chun Chung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

bone mineral density; cerebrotendinous xanthomatosis; cholestanol; osteoporosis

Indexed keywords

BICARBONATE; CALCIUM CARBONATE; CHENODEOXYCHOLIC ACID; CHOLESTEROL;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CASE REPORT; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; HUMAN; MALE; OSTEOPOROSIS; XANTHOMATOSIS;

ADULT; FEMALE; HUMANS; MALE; OSTEOPOROSIS; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 0030987109     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Salen G, Shefer S, Berginer VM: Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis and sitosterolemia with xanthomatosis. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, et al, eds. The Metabolic Basis of Inherited Diseases. 5th ed. New York. McGraw-Hill, 1983.713-30.
2. Cali JJ, Hsieh CL, Francke U, et al: Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991;266:7779-83.
3. Berginer VM, Shany S, Alkalay D, et al: Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 1993;42:69-74
4. Federico A, Dotti MT, Lore F, et al: Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism J Neurol Sci 1993;115:67-70
5. Chang WN, Kuriyama M, Lui CC, et al: Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family. J Formosan Med Assoc 1992;91:1190-4
6. Chang WN, Cheng YF: Nephrolithiasis and nephrocalcinosis in cerebrotendinous xanthomatosis: report of three siblings. Eur Neurol 1995;35:55-7.
7. Singh M, Nagrath AR, Maini PS: Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg 1970;52:457-67.
8. Vaananen HK: Pathogenesis of osteoporosis. Calcif Tissue Int 1991;49(Suppl.):S11-4.
9. Compston JE: Risk factors for osteoporosis. Clin Endocrinol 1992;36:223-4.
10. Bell NH, Epstein S, Shary J, et al: Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism J Bone Min Res 1988;3:489-95.
11. Miki H, Takeuchi H, Yamada A, et al: Quantitative analysis of the mitochondrial cytochrome P-450-linked monooxygenase system. NADPH-hepatoredoxin reductase, hepatoredoxin, and cytochrome P-450 SS 27 in livers of patients with cerebrotendinous xanthomatosis. Clin Chim Acta 1986;160:255-63
12. Courey WR, Pfister RC: The radiographic findings in renal tubular acidosis. Radiology 1972;105:497-503.
13. Caruana RJ, Buckalew VM. The syndrome of distal (type 1) renal tubular acidosis: clinical and laboratory findings in 58 cases. Medicine 1988;67:84-99.
14. Arruda JAL, Cowell G: Distal renal tubular acidosis: molecular and clinical aspects. Hosp Pract 1994;29:75-88.
15. Berginer VM, Berginer J, Korczyn AD, et al: Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study. J Neurol Sci 1994;122:102-8.